{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:03Z","timestamp":1792789683883,"version":"4.5.0"},"reference-count":112,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"MCIU\/AEI\/FEDER, UE","award":["PID2024-155394OB-I00 and PID2021-122629OB-I00"],"award-info":[{"award-number":["PID2024-155394OB-I00 and PID2021-122629OB-I00"]}]},{"DOI":"10.13039\/501100014139","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de C\u00e1ncer","doi-asserted-by":"publisher","award":["CB16\/12\/00275"],"award-info":[{"award-number":["CB16\/12\/00275"]}],"id":[{"id":"10.13039\/501100014139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Regional Ministry of Economic Transformation, Industry, Knowledge and Universities. Junta de Andaluc\u00eda.","award":["DGP_PIDI_2024_00907"],"award-info":[{"award-number":["DGP_PIDI_2024_00907"]}]},{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cientificas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Emerging evidence indicates that cancer is associated with widespread splicing alterations that generate tumour-specific isoforms. One example is NUMB, an evolutionarily conserved adaptor protein, which produces four isoforms (p72, p71, p66, and p65) through alternative splicing of exons 3 and 9. Although traditionally considered as a tumour suppressor, NUMB has also been reported as an oncogene. We propose that this dual role reflects isoform-specific expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Using public databases, we identify a tumour-associated switch in NUMB isoform expression: p72 and p71 are upregulated in tumours, whereas p66 and p65 are more highly expressed in non-tumour tissues. These isoforms show distinct associations with key cellular processes. NUMBL, a NUMB homolog, displays expression patterns similar to p65. We further identify two transcriptional clusters: one characterised by high expression of p72 and p71, and the other by enhanced p66\/p65\/NUMBL expression. These clusters exhibit differential associations with Notch, WNT\/\u03b2-catenin, Hedgehog, and Hippo signalling pathways, suggesting isoform-specific regulatory roles. In breast cancer cell lines, we develop a NUMB-score based on isoform expression, which classifies cell lines into biologically distinct groups. The p72\/p71-enriched group shows distinct signatures, pathway activity, and drug sensitivity. Application of this score to TCGA-BRCA samples reveals a significant link between high NUMB-score and poor survival, as confirmed by Kaplan\u2013Meier analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We find that NUMB emerges as a potential oncogenic contributor and biomarker in the context of splicing-based precision oncology, highlighting Isoform-specific expression as a clinical determinant of tumour behaviour, pathway activity, and therapeutic response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13059-026-04170-3","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T05:05:45Z","timestamp":1782277545000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumoral switch in NUMB splicing changes essential transcription pathways and induces malignant properties in tumour cells"],"prefix":"10.1186","volume":"27","author":[{"given":"Jos\u00e9 Manuel","family":"Garc\u00eda-Heredia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara M.","family":"Ortega-Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4357-3979","authenticated-orcid":false,"given":"Amancio","family":"Carnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"issue":"3","key":"4170_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/bfgp\/elr020","volume":"10","author":"AG Douglas","year":"2011","unstructured":"Douglas AG, Wood MJ. RNA splicing: disease and therapy. Brief Funct Genomics. 2011;10(3):151\u201364.","journal-title":"Brief Funct Genomics"},{"issue":"7871","key":"4170_CR2","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-021-03770-2","volume":"596","author":"AM Monteys","year":"2021","unstructured":"Monteys AM, et al. Regulated control of gene therapies by drug-induced splicing. Nature. 2021;596(7871):291\u20135.","journal-title":"Nature"},{"key":"4170_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12061381","author":"MA Rahman","year":"2020","unstructured":"Rahman MA, et al. Hallmarks of splicing defects in cancer: clinical applications in the era of personalized medicine. Cancers (Basel). 2020;12(6):1381.","journal-title":"Cancers (Basel)"},{"issue":"20","key":"4170_CR4","doi-asserted-by":"publisher","first-page":"2795","DOI":"10.2217\/fon.15.204","volume":"11","author":"AK Turnbull","year":"2015","unstructured":"Turnbull AK. Personalized medicine in cancer: where are we today? Future Oncol. 2015;11(20):2795\u20138.","journal-title":"Future Oncol"},{"issue":"7","key":"4170_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.cell.2024.02.041","volume":"187","author":"A Passaro","year":"2024","unstructured":"Passaro A, et al. Cancer biomarkers: emerging trends and clinical implications for personalized treatment. Cell. 2024;187(7):1617\u201335.","journal-title":"Cell"},{"issue":"1","key":"4170_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3892\/br.2017.922","volume":"7","author":"S Mathur","year":"2017","unstructured":"Mathur S, Sutton J. Personalized medicine could transform healthcare. Biomed Rep. 2017;7(1):3\u20135.","journal-title":"Biomed Rep"},{"key":"4170_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2020.102019","volume":"86","author":"AM Tsimberidou","year":"2020","unstructured":"Tsimberidou AM, et al. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"4170_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/ijc.28940","volume":"137","author":"SE Jackson","year":"2015","unstructured":"Jackson SE, Chester JD. Personalised cancer medicine. Int J Cancer. 2015;137(2):262\u20136.","journal-title":"Int J Cancer"},{"key":"4170_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600157","author":"A Fiszbein","year":"2017","unstructured":"Fiszbein A, Kornblihtt AR. Alternative splicing switches: important players in cell differentiation. Bioessays. 2017;39(6):e1600157.","journal-title":"Bioessays"},{"key":"4170_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-540-34449-0_2","volume":"44","author":"T Novoyatleva","year":"2006","unstructured":"Novoyatleva T, et al. Pre-mRNA missplicing as a cause of human disease. Prog Mol Subcell Biol. 2006;44:27\u201346.","journal-title":"Prog Mol Subcell Biol"},{"key":"4170_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/genes13030401","author":"Q Liu","year":"2022","unstructured":"Liu Q, Fang L, Wu C. Alternative splicing and isoforms: from mechanisms to diseases. Genes (Basel). 2022;13(3):401.","journal-title":"Genes (Basel)"},{"issue":"7","key":"4170_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00424-018-2136-x","volume":"470","author":"HK Kim","year":"2018","unstructured":"Kim HK, et al. Alternative splicing isoforms in health and disease. Pflugers Arch. 2018;470(7):995\u20131016.","journal-title":"Pflugers Arch"},{"issue":"12","key":"4170_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1182\/blood-2018-04-843771","volume":"132","author":"A Pellagatti","year":"2018","unstructured":"Pellagatti A, et al. Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes\/pathways and clinical associations. Blood. 2018;132(12):1225\u201340.","journal-title":"Blood"},{"key":"4170_CR14","doi-asserted-by":"publisher","unstructured":"Ladomery M. Aberrant alternative splicing is another hallmark of cancer. Int J Cell Biol. 2013;6. https:\/\/doi.org\/10.1155\/2013\/463786.","DOI":"10.1155\/2013\/463786"},{"issue":"1","key":"4170_CR15","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"3","key":"4170_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","volume":"23","author":"RK Bradley","year":"2023","unstructured":"Bradley RK, Anczuk\u00f3w O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23(3):135\u201355.","journal-title":"Nat Rev Cancer"},{"issue":"57","key":"4170_CR17","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.18632\/oncotarget.27215","volume":"10","author":"E Koedoot","year":"2019","unstructured":"Koedoot E, et al. Splicing regulatory factors in breast cancer hallmarks and disease progression. Oncotarget. 2019;10(57):6021\u201337.","journal-title":"Oncotarget"},{"issue":"3","key":"4170_CR18","first-page":"147","volume":"10","author":"J Yosudjai","year":"2019","unstructured":"Yosudjai J, et al. Aberrant mRNA splicing generates oncogenic RNA isoforms and contributes to the development and progression of cholangiocarcinoma. Biomed Rep. 2019;10(3):147\u201355.","journal-title":"Biomed Rep"},{"key":"4170_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1051487","volume":"12","author":"TI Shaw","year":"2022","unstructured":"Shaw TI, et al. Multi-omics approach to identifying isoform variants as therapeutic targets in cancer patients. Front Oncol. 2022;12:1051487.","journal-title":"Front Oncol"},{"issue":"12","key":"4170_CR20","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1093\/carcin\/bgs347","volume":"33","author":"K Miura","year":"2012","unstructured":"Miura K, Fujibuchi W, Unno M. Splice isoforms as therapeutic targets for colorectal cancer. Carcinogenesis. 2012;33(12):2311\u20139.","journal-title":"Carcinogenesis"},{"issue":"2","key":"4170_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1039\/C8MO00234G","volume":"15","author":"J Ma","year":"2019","unstructured":"Ma J, et al. Network-based approach to identify principal isoforms among four cancer types. Mol Omics. 2019;15(2):117\u201329.","journal-title":"Mol Omics"},{"key":"4170_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-319-89689-2_2","volume":"20","author":"RN Singh","year":"2018","unstructured":"Singh RN, Singh NN. Mechanism of splicing regulation of spinal muscular atrophy genes. Adv Neurobiol. 2018;20:31\u201361.","journal-title":"Adv Neurobiol"},{"issue":"1","key":"4170_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/immadv\/ltac009","volume":"2","author":"M Bogetofte Barnkob","year":"2022","unstructured":"Bogetofte Barnkob M, Vitting-Seerup K, R\u00f8nn Olsen L. Target isoforms are an overlooked challenge and opportunity in chimeric antigen receptor cell therapy. Immunother Adv. 2022;2(1):ltac009.","journal-title":"Immunother Adv"},{"issue":"1","key":"4170_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13046-020-01753-1","volume":"39","author":"A Di Matteo","year":"2020","unstructured":"Di Matteo A, et al. Alternative splicing in endothelial cells: novel therapeutic opportunities in cancer angiogenesis. J Exp Clin Cancer Res. 2020;39(1):275.","journal-title":"J Exp Clin Cancer Res"},{"issue":"25","key":"4170_CR25","doi-asserted-by":"publisher","first-page":"41701","DOI":"10.18632\/oncotarget.16678","volume":"8","author":"J Meng","year":"2017","unstructured":"Meng J. Distinct functions of dynamin isoforms in tumorigenesis and their potential as therapeutic targets in cancer. Oncotarget. 2017;8(25):41701\u201316.","journal-title":"Oncotarget"},{"issue":"6910","key":"4170_CR26","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nature01124","volume":"419","author":"PH Petersen","year":"2002","unstructured":"Petersen PH, et al. Progenitor cell maintenance requires numb and numblike during mouse neurogenesis. Nature. 2002;419(6910):929\u201334.","journal-title":"Nature"},{"issue":"12","key":"4170_CR27","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1038\/nn1202-1265","volume":"5","author":"M Cayouette","year":"2002","unstructured":"Cayouette M, Raff M. Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals. Nat Neurosci. 2002;5(12):1265\u20139.","journal-title":"Nat Neurosci"},{"issue":"39","key":"4170_CR28","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.1038\/onc.2016.69","volume":"35","author":"D Rajendran","year":"2016","unstructured":"Rajendran D, et al. Regulation of Numb isoform expression by activated ERK signaling. Oncogene. 2016;35(39):5202\u201313.","journal-title":"Oncogene"},{"key":"4170_CR29","doi-asserted-by":"crossref","unstructured":"Dho SE et al. Characterization of four mammalian numb protein isoforms. Identification of cytoplasmic and membrane-associated variants of the phosphotyrosine binding domain. J Biol Chem. 1999;274(46):33097\u2013104.","DOI":"10.1074\/jbc.274.46.33097"},{"key":"4170_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells12020333","author":"SM Ortega-Campos","year":"2023","unstructured":"Ortega-Campos SM, Garc\u00eda-Heredia JM. The multitasker protein: a look at the multiple capabilities of NUMB. Cells. 2023;12(2):333.","journal-title":"Cells"},{"issue":"3","key":"4170_CR31","first-page":"517","volume":"18","author":"M Katoh","year":"2006","unstructured":"Katoh M, Katoh M. NUMB is a break of WNT-Notch signaling cycle. Int J Mol Med. 2006;18(3):517\u201321.","journal-title":"Int J Mol Med"},{"issue":"25","key":"4170_CR32","doi-asserted-by":"publisher","first-page":"23196","DOI":"10.1074\/jbc.M302827200","volume":"278","author":"MA McGill","year":"2003","unstructured":"McGill MA, McGlade CJ. Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem. 2003;278(25):23196\u2013203.","journal-title":"J Biol Chem"},{"issue":"14","key":"4170_CR33","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1158\/1078-0432.CCR-16-2358","volume":"23","author":"JM Garcia-Heredia","year":"2017","unstructured":"Garcia-Heredia JM, et al. The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB. Clin Cancer Res. 2017;23(14):3871\u201383.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4170_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0896-6273(00)80278-0","volume":"17","author":"M Guo","year":"1996","unstructured":"Guo M, Jan LY, Jan YN. Control of daughter cell fates during asymmetric division: interaction of Numb and Notch. Neuron. 1996;17(1):27\u201341.","journal-title":"Neuron"},{"issue":"3","key":"4170_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.str.2015.12.015","volume":"24","author":"FJ Sorrell","year":"2016","unstructured":"Sorrell FJ, et al. Family-wide Structural Analysis of Human Numb-Associated Protein Kinases. Structure. 2016;24(3):401\u201311.","journal-title":"Structure"},{"issue":"5","key":"4170_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.mod.2011.02.002","volume":"128","author":"BJ Beres","year":"2011","unstructured":"Beres BJ, et al. Numb regulates Notch1, but not Notch3, during myogenesis. Mech Dev. 2011;128(5):247\u201357.","journal-title":"Mech Dev"},{"issue":"3","key":"4170_CR37","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.bbrc.2011.08.108","volume":"413","author":"L Liu","year":"2011","unstructured":"Liu L, et al. Numblike and Numb differentially affect p53 and Sonic Hedgehog signaling. Biochem Biophys Res Commun. 2011;413(3):426\u201331.","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"4170_CR38","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/ncb1510","volume":"8","author":"L Di Marcotullio","year":"2006","unstructured":"Di Marcotullio L, et al. Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination. Nat Cell Biol. 2006;8(12):1415\u201323.","journal-title":"Nat Cell Biol"},{"issue":"3","key":"4170_CR39","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/onc.2016.221","volume":"36","author":"SK Saha","year":"2017","unstructured":"Saha SK, et al. KRT19 directly interacts with \u03b2-catenin\/RAC1 complex to regulate NUMB-dependent NOTCH signaling pathway and breast cancer properties. Oncogene. 2017;36(3):332\u201349.","journal-title":"Oncogene"},{"issue":"10","key":"4170_CR40","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/ncb2313","volume":"13","author":"C Kwon","year":"2011","unstructured":"Kwon C, et al. Notch post-translationally regulates \u03b2-catenin protein in stem and progenitor cells. Nat Cell Biol. 2011;13(10):1244\u201351.","journal-title":"Nat Cell Biol"},{"key":"4170_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2019.104262","volume":"109","author":"XB Hu","year":"2019","unstructured":"Hu XB, et al. Numb confers to inhibit epithelial mesenchymal transition via \u03b2-catenin\/Lin28 signaling pathway in breast cancer. Exp Mol Pathol. 2019;109:104262.","journal-title":"Exp Mol Pathol"},{"key":"4170_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6032076","volume":"2022","author":"X Qin","year":"2022","unstructured":"Qin X, Cao Y. Prognostic biomarker NUMB is inhibited by breast cancer cell exosomes to promote breast cancer progression. J Immunol Res. 2022;2022:6032076.","journal-title":"J Immunol Res"},{"issue":"38","key":"4170_CR43","doi-asserted-by":"publisher","first-page":"61036","DOI":"10.18632\/oncotarget.11062","volume":"7","author":"J Zhang","year":"2016","unstructured":"Zhang J, et al. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling. Oncotarget. 2016;7(38):61036\u201353.","journal-title":"Oncotarget"},{"issue":"2","key":"4170_CR44","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10549-009-0568-x","volume":"122","author":"K Rennstam","year":"2010","unstructured":"Rennstam K, et al. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer. Breast Cancer Res Treat. 2010;122(2):315\u201324.","journal-title":"Breast Cancer Res Treat"},{"issue":"269","key":"4170_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"issue":"W1","key":"4170_CR46","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556-w560.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"4170_CR47","doi-asserted-by":"publisher","first-page":"9219","DOI":"10.18632\/oncotarget.24186","volume":"9","author":"JM Garc\u00eda-Heredia","year":"2018","unstructured":"Garc\u00eda-Heredia JM, Carnero A. Numb and NUMBL differences in gene regulation. Oncotarget. 2018;9(10):9219\u201334.","journal-title":"Oncotarget"},{"issue":"10","key":"4170_CR48","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1534\/g3.119.400494","volume":"9","author":"S Confalonieri","year":"2019","unstructured":"Confalonieri S, et al. Exon 3 of the NUMB gene emerged in the chordate lineage coopting the NUMB protein to the regulation of MDM2. G3 (Bethesda). 2019;9(10):3359\u201367.","journal-title":"G3 (Bethesda)"},{"issue":"1","key":"4170_CR49","first-page":"26","volume":"1815","author":"S Pece","year":"2011","unstructured":"Pece S, et al. NUMB-ing down cancer by more than just a NOTCH. Biochim Biophys Acta. 2011;1815(1):26\u201343.","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"4170_CR50","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.devcel.2008.11.010","volume":"15","author":"J Jiang","year":"2008","unstructured":"Jiang J, Hui C-c. Hedgehog signaling in development and cancer. Dev Cell. 2008;15(6):801\u201312.","journal-title":"Dev Cell"},{"key":"4170_CR51","doi-asserted-by":"publisher","DOI":"10.21037\/gpm-23-30","author":"H Wang","year":"2023","unstructured":"Wang H, et al. Numb suppression promoted the pathogenesis of SiHa cells by stimulating Notch and Hedgehog signaling pathways. Gynecol Pelvic Med. 2023. https:\/\/doi.org\/10.21037\/gpm-23-30.","journal-title":"Gynecol Pelvic Med"},{"key":"4170_CR52","doi-asserted-by":"publisher","DOI":"10.1172\/JCI168888","author":"D Su","year":"2023","unstructured":"Su D, et al. SPTAN1\/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signaling. J Clin Invest. 2023. https:\/\/doi.org\/10.1172\/JCI168888.","journal-title":"J Clin Invest"},{"issue":"3","key":"4170_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108215","volume":"301","author":"SE Dho","year":"2025","unstructured":"Dho SE, et al. NUMB alternative splicing and isoform-specific functions in development and disease. J Biol Chem. 2025;301(3):108215.","journal-title":"J Biol Chem"},{"issue":"4","key":"4170_CR54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0095849","volume":"9","author":"J Wu","year":"2014","unstructured":"Wu J, et al. Numb promotes cell proliferation and correlates with poor prognosis in hepatocellular carcinoma. PLoS ONE. 2014;9(4):e95849.","journal-title":"PLoS ONE"},{"issue":"14","key":"4170_CR55","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/s41388-022-02225-w","volume":"41","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Numb exon 9 inclusion regulates Integrin\u03b25 surface expression and promotes breast cancer metastasis. Oncogene. 2022;41(14):2079\u201394.","journal-title":"Oncogene"},{"issue":"10","key":"4170_CR56","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1534\/g3.119.400494","volume":"9","author":"S Confalonieri","year":"2019","unstructured":"Confalonieri S, et al. Exon 3 of the NUMB gene emerged in the chordate lineage coopting the NUMB protein to the regulation of MDM2. G3 (Bethesda). 2019;9(10):3359\u201367.","journal-title":"G3 (Bethesda)"},{"issue":"15","key":"4170_CR57","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1089\/ars.2017.7432","volume":"30","author":"Z Liu","year":"2019","unstructured":"Liu Z, et al. Numb depletion promotes Drp1-mediated mitochondrial fission and exacerbates mitochondrial fragmentation and dysfunction in acute kidney injury. Antioxid Redox Signal. 2019;30(15):1797\u2013816.","journal-title":"Antioxid Redox Signal"},{"key":"4170_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112033","author":"Y He","year":"2023","unstructured":"He Y, et al. Numb\/Parkin-directed mitochondrial fitness governs cancer cell fate via metabolic regulation of histone lactylation. Cell Rep. 2023. https:\/\/doi.org\/10.1016\/j.celrep.2023.112033.","journal-title":"Cell Rep"},{"issue":"11","key":"4170_CR59","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/jmcb\/mjz003","volume":"11","author":"R Wei","year":"2019","unstructured":"Wei R, et al. NUMB regulates the endocytosis and activity of the anaplastic lymphoma kinase in an isoform-specific manner. J Mol Cell Biol. 2019;11(11):994\u20131005.","journal-title":"J Mol Cell Biol"},{"key":"4170_CR60","unstructured":"Zhang Y, McGlade CJ. Pan tissue analysis of human NUMB alternative splicing. bioRxiv. 2023:2023.09.26.559629."},{"key":"4170_CR61","doi-asserted-by":"crossref","unstructured":"Abballe L, et al. Numb Isoforms Deregulation in Medulloblastoma and Role of p66 Isoform in Cancer and Neural Stem Cells. Front Pediatr. 2018;6:2018.","DOI":"10.3389\/fped.2018.00315"},{"issue":"39","key":"4170_CR62","doi-asserted-by":"publisher","first-page":"63611","DOI":"10.18632\/oncotarget.11553","volume":"7","author":"JM Garc\u00eda-Heredia","year":"2016","unstructured":"Garc\u00eda-Heredia JM, et al. Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy. Oncotarget. 2016;7(39):63611\u201328.","journal-title":"Oncotarget"},{"issue":"1","key":"4170_CR63","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1128\/MCB.00709-10","volume":"31","author":"CM Misquitta-Ali","year":"2011","unstructured":"Misquitta-Ali CM, et al. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol Cell Biol. 2011;31(1):138\u201350.","journal-title":"Mol Cell Biol"},{"issue":"2","key":"4170_CR64","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1083\/jcb.201709092","volume":"217","author":"IN Colaluca","year":"2018","unstructured":"Colaluca IN, et al. A Numb-Mdm2 fuzzy complex reveals an isoform-specific involvement of Numb in breast cancer. J Cell Biol. 2018;217(2):745\u201362.","journal-title":"J Cell Biol"},{"issue":"4","key":"4170_CR65","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/hep.27923","volume":"62","author":"Y Lu","year":"2015","unstructured":"Lu Y, et al. Alternative splicing of the cell fate determinant Numb in hepatocellular carcinoma. Hepatology. 2015;62(4):1122\u201331.","journal-title":"Hepatology"},{"issue":"7","key":"4170_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5483\/BMBRep.2021.54.7.048","volume":"54","author":"HY Choi","year":"2021","unstructured":"Choi HY, et al. The role of NUMB\/NUMB isoforms in cancer stem cells. BMB Rep. 2021;54(7):335\u201343.","journal-title":"BMB Rep"},{"issue":"2","key":"4170_CR67","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1074\/mcp.M112.020768","volume":"12","author":"JR Krieger","year":"2013","unstructured":"Krieger JR, et al. Identification and selected reaction monitoring (SRM) quantification of endocytosis factors associated with Numb*. Mol Cell Proteomics. 2013;12(2):499\u2013514.","journal-title":"Mol Cell Proteomics"},{"issue":"11","key":"4170_CR68","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1074\/mcp.RA117.000114","volume":"17","author":"R Wei","year":"2018","unstructured":"Wei R, et al. Interactome Mapping Uncovers a General Role for Numb in Protein Kinase Regulation. Mol Cell Proteomics. 2018;17(11):2216\u201328.","journal-title":"Mol Cell Proteomics"},{"issue":"21","key":"4170_CR69","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1101\/gad.1602907","volume":"21","author":"B Zhao","year":"2007","unstructured":"Zhao B, et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 2007;21(21):2747\u201361.","journal-title":"Genes Dev"},{"issue":"2","key":"4170_CR70","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/s41419-017-0244-8","volume":"9","author":"F Deng","year":"2018","unstructured":"Deng F, et al. YAP triggers the Wnt\/\u03b2-catenin signalling pathway and promotes enterocyte self-renewal, regeneration and tumorigenesis after DSS-induced injury. Cell Death Dis. 2018;9(2):153.","journal-title":"Cell Death Dis"},{"key":"4170_CR71","doi-asserted-by":"crossref","unstructured":"Engel-Pizcueta C, Pujades C. Interplay Between Notch and YAP\/TAZ Pathways in the Regulation of Cell Fate During Embryo Development. Front Cell Develop Biol. 2021;9:2021.","DOI":"10.3389\/fcell.2021.711531"},{"issue":"1","key":"4170_CR72","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12964-024-01662-2","volume":"22","author":"IA Govorova","year":"2024","unstructured":"Govorova IA, Nikitochkina SY, Vorotelyak EA. Influence of intersignaling crosstalk on the intracellular localization of YAP\/TAZ in lung cells. Cell Commun Signal. 2024;22(1):289.","journal-title":"Cell Commun Signal"},{"issue":"50","key":"4170_CR73","doi-asserted-by":"publisher","first-page":"29379","DOI":"10.18632\/oncotarget.25585","volume":"9","author":"H Kikuchi","year":"2018","unstructured":"Kikuchi H, et al. Numb has distinct function in lung adenocarcinoma and squamous cell carcinoma. Oncotarget. 2018;9(50):29379\u201391.","journal-title":"Oncotarget"},{"issue":"25","key":"4170_CR74","doi-asserted-by":"publisher","first-page":"17990","DOI":"10.1074\/jbc.M113.478487","volume":"288","author":"XH Liu","year":"2013","unstructured":"Liu XH, et al. Androgens up-regulate transcription of the Notch inhibitor Numb in C2C12 myoblasts via Wnt\/\u03b2-catenin signaling to T cell factor elements in the Numb promoter. J Biol Chem. 2013;288(25):17990\u20138.","journal-title":"J Biol Chem"},{"issue":"4","key":"4170_CR75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004289","volume":"10","author":"FY Zong","year":"2014","unstructured":"Zong FY, et al. The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet. 2014;10(4):e1004289.","journal-title":"PLoS Genet"},{"issue":"9","key":"4170_CR76","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1158\/1541-7786.MCR-16-0459","volume":"15","author":"K Vitting-Seerup","year":"2017","unstructured":"Vitting-Seerup K, Sandelin A. The landscape of isoform switches in human cancers. Mol Cancer Res. 2017;15(9):1206\u201320.","journal-title":"Mol Cancer Res"},{"issue":"21","key":"4170_CR77","doi-asserted-by":"publisher","first-page":"4469","DOI":"10.1093\/bioinformatics\/btz247","volume":"35","author":"K Vitting-Seerup","year":"2019","unstructured":"Vitting-Seerup K, Sandelin A. IsoformSwitchAnalyzeR: analysis of changes in genome-wide patterns of alternative splicing and its functional consequences. Bioinformatics. 2019;35(21):4469\u201371.","journal-title":"Bioinformatics"},{"issue":"6","key":"4170_CR78","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ccr.2006.10.009","volume":"10","author":"K Chin","year":"2006","unstructured":"Chin K, et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell. 2006;10(6):529\u201341.","journal-title":"Cancer Cell"},{"issue":"2","key":"4170_CR79","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s10549-010-0897-9","volume":"126","author":"R Sabatier","year":"2011","unstructured":"Sabatier R, et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer. Breast Cancer Res Treat. 2011;126(2):407\u201320.","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"4170_CR80","doi-asserted-by":"publisher","first-page":"R953","DOI":"10.1186\/bcr1325","volume":"7","author":"Y Pawitan","year":"2005","unstructured":"Pawitan Y, et al. Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res. 2005;7(6):R953\u201364.","journal-title":"Breast Cancer Res"},{"key":"4170_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-143","volume":"11","author":"KJ Kao","year":"2011","unstructured":"Kao KJ, et al. Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization. BMC Cancer. 2011;11:143.","journal-title":"BMC Cancer"},{"issue":"18","key":"4170_CR82","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1001\/jama.2011.593","volume":"305","author":"C Hatzis","year":"2011","unstructured":"Hatzis C, et al. A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer. JAMA. 2011;305(18):1873\u201381.","journal-title":"JAMA"},{"issue":"10","key":"4170_CR83","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1093\/carcin\/bgt208","volume":"34","author":"C Clarke","year":"2013","unstructured":"Clarke C, et al. Correlating transcriptional networks to breast cancer survival: a large-scale coexpression analysis. Carcinogenesis. 2013;34(10):2300\u20138.","journal-title":"Carcinogenesis"},{"key":"4170_CR84","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20211428","author":"YJ Chen","year":"2021","unstructured":"Chen YJ, et al. Molecular subtyping of breast cancer intrinsic taxonomy with oligonucleotide microarray and NanoString nCounter. Biosci Rep. 2021. https:\/\/doi.org\/10.1042\/BSR20211428.","journal-title":"Biosci Rep"},{"issue":"2","key":"4170_CR85","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10549-008-0183-2","volume":"116","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, et al. The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy. Breast Cancer Res Treat. 2009;116(2):303\u20139.","journal-title":"Breast Cancer Res Treat"},{"key":"4170_CR86","unstructured":"Chin K, et al. caArray_gray-00248: Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. 2015; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE69031."},{"key":"4170_CR87","unstructured":"Sabatier R, et al. A gene expression signature identifies two prognostic subgroups of basal breast cancer. 2010; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=gse21653."},{"key":"4170_CR88","unstructured":"Pawitan Y, et al. Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients. 2006; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE1456."},{"key":"4170_CR89","unstructured":"Kao KJ. Microarray-based molecular subtyping of breast cancer. 2011; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE20685."},{"key":"4170_CR90","doi-asserted-by":"crossref","unstructured":"Hatzis C, et al. Genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer. 2011; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE25066.","DOI":"10.1001\/jama.2011.593"},{"key":"4170_CR91","unstructured":"Clarke C, et al. Breast Cancer Gene Expression Analysis. 2013; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE42568."},{"key":"4170_CR92","unstructured":"Chen Y, et al. Concordance of PAM50 molecular subtyping between oligonucleotide microarray and NanoString nCounter assay for Taiwanese breast cancer. 2021; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE162228."},{"key":"4170_CR93","unstructured":"Zhang Y, Wang Y, Fokens J. The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy. 2008; Available from: https:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE12093."},{"issue":"10","key":"4170_CR94","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"K Chang","year":"2013","unstructured":"Chang K, et al. The Cancer Genome Atlas Pan-Cancer analysis project. Nat Genet. 2013;45(10):1113\u201320.","journal-title":"Nat Genet"},{"issue":"7418","key":"4170_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, et al. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"1","key":"4170_CR96","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41588-020-00750-6","volume":"53","author":"XY Woo","year":"2021","unstructured":"Woo XY, et al. Conservation of copy number profiles during engraftment and passaging of patient-derived cancer xenografts. Nat Genet. 2021;53(1):86\u201399.","journal-title":"Nat Genet"},{"issue":"7757","key":"4170_CR97","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi M, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569(7757):503\u20138.","journal-title":"Nature"},{"key":"4170_CR98","unstructured":"Maechler M. diptest: Hartigan\u2019s Dip Test Statistic for Unimodality.\u00a0R package. 2022. Available at:\u00a0https:\/\/CRAN.R-project.org\/package=diptest."},{"key":"4170_CR99","unstructured":"Kolde R. pheatmap:\u00a0Pretty Heatmaps. R package. 2019. Available at:\u00a0https:\/\/CRAN.R-project.org\/package=pheatmap."},{"issue":"18","key":"4170_CR100","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","volume":"33","author":"JR Conway","year":"2017","unstructured":"Conway JR, Lex A, Gehlenborg N. UpSetR: an R package for the visualization of intersecting sets and their properties. Bioinformatics. 2017;33(18):2938\u201340.","journal-title":"Bioinformatics"},{"issue":"5","key":"4170_CR101","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"19","key":"4170_CR102","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1093\/bioinformatics\/btu393","volume":"30","author":"Z Gu","year":"2014","unstructured":"Gu Z, et al. Circlize implements and enhances circular visualization in R. Bioinformatics. 2014;30(19):2811\u20132.","journal-title":"Bioinformatics"},{"issue":"7","key":"4170_CR103","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47\u2013e47.","journal-title":"Nucleic Acids Res"},{"key":"4170_CR104","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00858","volume":"10","author":"E Ulgen","year":"2019","unstructured":"Ulgen E, Ozisik O, Sezerman OU. PathfindR: an R package for comprehensive identification of enriched pathways in omics data through active subnetworks. Front Genet. 2019;10:2019.","journal-title":"Front Genet"},{"key":"4170_CR105","unstructured":"Melville J. uwot: The Uniform Manifold Approximation and Projection (UMAP) Method for Dimensionality Reduction.\u00a0R package. 2025. Available at: https:\/\/CRAN.R-project.org\/package=uwot."},{"key":"4170_CR106","doi-asserted-by":"publisher","DOI":"10.21105\/joss.02017","author":"JC Brunson","year":"2020","unstructured":"Brunson JC. Ggalluvial: layered grammar for alluvial plots. J Open Source Softw. 2020. https:\/\/doi.org\/10.21105\/joss.02017.","journal-title":"J Open Source Softw"},{"issue":"D1","key":"4170_CR107","doi-asserted-by":"publisher","first-page":"D955","DOI":"10.1093\/nar\/gks1111","volume":"41","author":"W Yang","year":"2012","unstructured":"Yang W, et al. Genomics of drug sensitivity in cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res. 2012;41(D1):D955\u201361.","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4170_CR108","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, et al. A Landscape of Pharmacogenomic Interactions in Cancer. Cell. 2016;166(3):740\u201354.","journal-title":"Cell"},{"key":"4170_CR109","unstructured":"Therneau TM. survival: A Package for Survival Analysis in R. R package. 2024. Available at: https:\/\/CRAN.R-project.org\/package=survival."},{"key":"4170_CR110","unstructured":"Kassambara A, Kosinski M, Biecek P. survminer: Drawing survival curves using ggplot2.\u00a0R package.\u00a02021. Available at: https:\/\/CRAN.R-project.org\/package=survminer."},{"key":"4170_CR111","doi-asserted-by":"crossref","unstructured":"Garcia-Heredia JM, Ortega-Campos SM, Carnero A. Code and metadata for: Tumoral switch in NUMB splicing changes essential transcription pathways and induces malignant properties of tumours cells. 2026; Available from: https:\/\/github.com\/jmgheredia\/NUMB-tumoral-switch.","DOI":"10.64898\/2026.05.15.725391"},{"key":"4170_CR112","doi-asserted-by":"publisher","unstructured":"Garc\u00eda-Heredia JM, Ortega-Campos SM, Carnero A. Code and metadata for: Tumoral switch in NUMB splicing changes essential transcription pathways and induces malignant properties in tumour cells. 2026; Available from: https:\/\/doi.org\/10.5281\/zenodo.18522980.","DOI":"10.5281\/zenodo.18522980"}],"container-title":["Genome Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13059-026-04170-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-04170-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13059-026-04170-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:02:49Z","timestamp":1788829369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13059-026-04170-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":112,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4170"],"URL":"https:\/\/doi.org\/10.1186\/s13059-026-04170-3","relation":{},"ISSN":["1474-760X"],"issn-type":[{"value":"1474-760X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"assertion":[{"value":"15 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"285"}}